Post-operative atrial fibrillation: should we anticoagulate?
نویسندگان
چکیده
منابع مشابه
Assessment of risk of thromboembolism in atrial fibrillation: which patient should we anticoagulate?
Assessment of the risk of a thromboembolic complication in a patient with atrial fibrillation is no easy task and the decision to initiate anticoagulation, albeit a common every day problem, often remains a dilemma for the clinician. Guidelines have been published by different organizations to help the physician make the optimal decision in each individual case. Some of these guidelines are pre...
متن کاملPost-Operative Atrial Fibrillation and Oxidative Stress
ver the last decade there has been substantial progress in nderstanding the pathogenesis of atrial fibrillation (AF), rimarily due to the recognition of the role of the pulmonary eins and their antral regions in the initiation and perpetation of AF (1,2). Much work has focused on the electrohysiological (3,4), anatomical, and histological properties f the pulmonary veins (5); how they initiate ...
متن کاملThe Decision to Anticoagulate Patients With Atrial Fibrillation
Background—The rate of ischemic stroke associated with traditional risk factors for patients with atrial fibrillation has declined over the past 2 decades. Furthermore, new and potentially safer anticoagulants are on the horizon. Thus, the balance between risk factors for stroke and benefit of anticoagulation may be shifting. Methods and Results—The Markov state transition decision model was us...
متن کاملCerebrovascular Accident due to Thyroid Storm: Should We Anticoagulate?
Thyroid storm is a life-threatening condition that occurs secondary to an uncontrolled hyperthyroid state. Atrial fibrillation is a cardiovascular complication occurring in up to 15% of patients experiencing thyroid storm, and if left untreated this condition could have up to a 25% mortality rate. Thyroid storm with stroke is a rare presentation. This case report details a left middle cerebral ...
متن کاملStroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
For every patient with atrial fibrillation (AF) one of the first decisions to be made is whether to recommend anticoagulation. For this decision the physician needs to weigh the benefit of reducing the risk of thromboembolism against the risk of causing serious bleeding by treatment. Randomised controlled trials provide the strongest evidence and have in AF patients demonstrated that vitamin K ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Translational Medicine
سال: 2019
ISSN: 2305-5839,2305-5847
DOI: 10.21037/atm.2019.07.10